Canopy Growth shares move higher after another Wall St brokerage backs it
US brokerage Piper Jaffray has begun covering cannabis producers helping boost the share price of listed players in the sector.
Canopy Growth climbed higher once again on Friday, after investors were imbued with confidence in the future of the burgeoning cannabis sector following an announcement by US brokerage Piper Jaffray that it has begun covering the industry.
The news sees Piper Jaffray join a growing list of brokerages watching the cannabis sector, which has helped other listed players share prices rise as investors grow in confidence about the industry.
Tilray and Canopy Growth receive overweight ratings
In a note to investors on Tuesday Piper Jaffray analyst Michal Lavery set overweight ratings for two Candada-based cannabis companies Tilray and Canopy Growth, forecasting strong growth for industry in 2019.
‘We do believe the long-term growth opportunities are significant — both from transitioning illicit trade to legal sales, medical sales, and from transitioning sales in health & wellness categories to CBD-infused products,’ he said.
‘While timing of further changes is difficult to predict, the pace of further legalization appears to be accelerating’
High times for Canadian cannabis companies
Shares in Canopy Growth and Tilray have ended the week on a high, cup 5% and 22% as of 4:21pm GMT on Friday.
Analysts believe that the sector has huge potential, with Cowen analyst Vivien Azer believing that US cannabis sales will soar to $80 billion by 2030, with Lavery sharing similar sentiments for the Canadian market.
‘We expect legal recreational marijuana to source from illicit trade and could attract new users to the category, while THC-infused drinks could source share from alcoholic beverages,’ Lavery added.
‘Medical cannabis can replace a variety of products (e.g. pain relief, sleep aid, opioid replacement). CBD-infused products (with non-psychoactive properties) could gain share from food, beverage, and personal care categories.’
IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.
The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.
Please see important Research Disclaimer.
See an opportunity to trade?
Go long or short on more than 17,000 markets with IG.
Trade CFDs on our award-winning platform, with low spreads on indices, shares, commodities and more.
Live prices on most popular markets
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.